Upon inflammation, that is often associated with cancer, F11R/JAM-A molecules are relocated from endothelial TJs to the apical endothelial surface that faces the vessel lumen, where they interact with leukocyte and cancer cells surface proteins, including F11R/JAM-A (by trans-homodimerization) and integrins [24]. The gene discussed is F11R; the disease is cancer.